- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Acuson sells 10 echo units to Health First
Ultrasound vendor Acuson scored a coup this month when it sold 10 echocardiography systems, combined with its KinetDx PACS product, to Health First Heart Institute of Brevard, FL. Health First has installed one of Acuson’s Aspen units and
Ultrasound vendor Acuson scored a coup this month when it sold 10 echocardiography systems, combined with its KinetDx PACS product, to Health First Heart Institute of Brevard, FL. Health First has installed one of Acusons Aspen units and nine of its Sequoia C256 units, along with KinetDx, at hospitals and clinics in its network: Cape Canaveral Hospital, Palm Bay Community Hospital, Health First Healthplex Outpatient Clinic, and Holmes Regional Medical Center. The Aspen and Sequoia systems will include Acusons Imagegate hardware and software upgrade package, which it launched in September (SCAN 9/15/99).
Acuson introduced KinetDx in April at the Symposium for Computer Applications in Radiology in Houston (SCAN 5/12/99). KinetDx will link all four of Health Firsts facilities into a single network.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
